CJC 1295 no DAC IPA dosage is not FDA-approved. Learn typical research protocols, ipamorelin blends, dosage charts, and safety for US researchers.
There is no FDA-approved cjc 1295 no dac ipa dosage for human use. In research settings, the combination of CJC-1295 without DAC (Mod GRF 1-29) and ipamorelin is commonly studied at about 100 mcg of each peptide per injection, one to three times per day. These are experimental protocols, not medical recommendations, and anyone considering peptide use should consult a licensed healthcare professional.
What Is CJC-1295 No DAC and Ipamorelin?
CJC-1295 no DAC is a synthetic analog of growth hormone-releasing hormone (GHRH). It is also called Mod GRF 1-29 because it lacks the Drug Affinity Complex (DAC) that extends half-life. Ipamorelin is a selective growth hormone secretagogue that mimics ghrelin.
Researchers often pair them because they stimulate growth hormone release through different pathways. A standard cjc-1295 no dac dosage is usually expressed in micrograms per injection, and ipamorelin is matched at a 1:1 ratio. Neither peptide is FDA-approved for human use in the United States.
Typical Research Dosages for CJC-1295 No DAC + Ipamorelin
Most published research protocols and online guides suggest the following ranges for laboratory studies:
- CJC-1295 no DAC: 100 mcg per injection
- Ipamorelin: 100 mcg per injection
- Frequency: 1 to 3 times daily
- Cycle length: 8 to 12 weeks, often with 5 days on and 2 days off
For a pre-mixed vial, the cjc-1295 no dac ipamorelin 10mg blend dosage is calculated after reconstitution. A 10 mg blend typically contains 5 mg of each peptide. If you add 2.5 mL of bacteriostatic water, each 0.1 mL (10 units on an insulin syringe) delivers 200 mcg of total peptide, or 100 mcg of each.
These numbers are for research context only. Individual response varies, and no universal dose exists for CJC-1295 no DAC and ipamorelin.
CJC-1295 No DAC vs. CJC-1295 With DAC: Dosage Differences
DAC stands for Drug Affinity Complex. It binds to albumin and extends the half-life of CJC-1295 from minutes to days. That changes dosing frequency and amount.
| Peptide | Half-Life | Typical Research Dose | Frequency |
|---|---|---|---|
| CJC-1295 no DAC (Mod GRF 1-29) | ~30 minutes | 100 mcg | 1–3 times daily |
| CJC-1295 with DAC | ~6–8 days | 1–2 mg | 1–2 times weekly |
The cjc-1295 with dac dosage is much lower in frequency because the peptide remains active longer. Many researchers prefer the no-DAC version for more physiological pulsatility.
CJC-1295 No DAC Dosage Chart for Research
A simple cjc-1295 no dac dosage chart can help researchers plan injections. The chart below assumes a 1:1 blend with ipamorelin and a 10 mg vial reconstituted with 2.5 mL of bacteriostatic water.
| Total Peptide per Injection | CJC-1295 No DAC | Ipamorelin | Volume on Insulin Syringe |
|---|---|---|---|
| 200 mcg | 100 mcg | 100 mcg | 10 units (0.1 mL) |
| 300 mcg | 150 mcg | 150 mcg | 15 units (0.15 mL) |
| 400 mcg | 200 mcg | 200 mcg | 20 units (0.2 mL) |
This chart is for educational purposes only. It is not a prescription or a recommendation for human use.
What Reddit Users Say About CJC 1295 No DAC Ipamorelin
On cjc 1295 no dac ipamorelin reddit threads, users frequently discuss starting doses around 100 mcg of each peptide. Many report injecting before bed to mimic natural growth hormone pulses.
Reddit anecdotes are not clinical evidence. Users often mention side effects like flushing, hunger, and injection-site irritation. Some also report no noticeable effects.
Always treat forum posts as personal experiences, not medical advice.
Safety, Legality, and Medical Guidance
CJC-1295 no DAC and ipamorelin are not FDA-approved for human use in the United States. They are classified as research chemicals, and selling them for human consumption is illegal.
Potential side effects reported in research include increased hunger, water retention, and joint pain. Long-term safety data in humans are lacking.
Anyone considering peptide therapy should consult a licensed healthcare professional. Self-dosing with research chemicals carries unknown risks.
Frequently Asked Questions
What is the typical CJC 1295 no DAC ipamorelin dosage?
Research protocols often use 100 mcg of CJC-1295 no DAC and 100 mcg of ipamorelin per injection, one to three times daily. Some users adjust to 200 mcg of each. These are experimental doses, not FDA-approved guidelines. Consult a doctor before considering any peptide.
Is CJC 1295 no DAC the same as CJC-1295 with DAC?
No. CJC-1295 no DAC (Mod GRF 1-29) has a short half-life of about 30 minutes, so it is injected 1–3 times daily. CJC-1295 with DAC lasts 6–8 days and is dosed 1–2 times weekly. The two are not interchangeable.
Is CJC 1295 no DAC ipamorelin legal in the US?
These peptides are not FDA-approved for human use. They are legal to purchase for laboratory research only. Using them for personal human consumption is not approved and may violate FDA regulations. Consult a healthcare attorney or doctor for guidance.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.